Clinical Trials for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Find clinical trials for anti-neutrophil cytoplasmic antibody-associated vasculitis. Discover research opportunities and treatment options in your area.

9 Active Trials Found

Showing 9 trials on this page

Page 1 of 1

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

NCT ID: NCT03323476

This clinical trial is looking at whether patients with a specific type of kidney disease, known as ANCA-associated vasculitis (AAV), who are also in end-stage renal disease (ESRD), can stop taking...

Recruiting

Phase: PHASE3 Type: interventional Locations: Tours, , France, Paris, , France +55 more

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT ID: NCT06978647

This clinical trial is looking at a new treatment called YTS109 cells for adults who have relapsed or refractory autoimmune diseases, which means their conditions have either come back or have not ...

Not yet recruiting

Phase: PHASE1 Type: interventional

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

NCT ID: NCT06294236

The GLEAM trial is a research study looking at a new treatment called SC291 for people with severe autoimmune diseases, such as lupus and certain types of vasculitis. This Phase 1 trial aims to und...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Atlanta, Georgia, United States +3 more

Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

NCT ID: NCT06226662

This clinical trial is studying a new medication called NM8074 to see if it is safe and effective for patients with a condition known as Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (...

Not yet recruiting

Phase: PHASE2 Type: interventional

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)

NCT ID: NCT06350110

This clinical trial is investigating a new treatment using a type of engineered immune cells called CAR T cells to help patients with systemic lupus erythematosus (SLE) who have not responded to ot...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China, Beijing, Beijing, China

An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease

NCT ID: NCT06379646

This clinical trial is looking at a new treatment called YTS109 cell injection for patients with certain autoimmune diseases, such as systemic lupus erythematosus and Sjogren's syndrome, that have ...

Recruiting

Phase: NA Type: interventional Locations: Shanghai, Shanghai, China

Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases

NCT ID: NCT06316076

This clinical trial is studying a new treatment called CD19-CAR-DNT cells for patients with certain autoimmune diseases, including Systemic Lupus Erythematosus, vasculitis, inflammatory myopathies,...

Recruiting

Phase: PHASE1 Type: interventional Locations: Shanghai, , China

Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease

NCT ID: NCT06056921

This clinical trial is investigating a new treatment called CD19 targeted CAR-T therapy for patients suffering from certain autoimmune diseases, including Systemic Lupus Erythematosus (SLE), Sjogre...

Recruiting

Phase: PHASE1 Type: interventional Locations: Taiyuan, Shanxi, China

Stratified Therapy on Pediatric AAGN

NCT ID: NCT05969522

This clinical trial is looking at how different treatments affect children with a condition called ANCA-associated nephritis, which is a type of kidney inflammation. The goal is to see how well the...

Recruiting

Phase: PHASE4 Type: interventional Locations: Chongqing, Chongqing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions